APREMILAST Leman cpr pellic 10 mg 4+4+19 pce

7680695140019 CH-69514 L04AA32 07.15.0.

Active substances:

Apremilastum

No images available

Details

Product number
6951401
CPT
-
Packaging group
4 + 4 + 19
Unit
Tablette(n)
Composition
I) 10 mg: apremilastum 10 mg, carmellosum natricum conexum corresp. natrium max. 0.36 mg, lactosum 47.5 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, pellicule: hydroxypropylcellulosum, hypromellosum, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto. II) 20 mg: apremilastum 20 mg, carmellosum natricum conexum corresp. natrium max. 0.72 mg, lactosum 95 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, pellicule: hydroxypropylcellulosum, hypromellosum, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto. III) 30 mg: apremilastum 30 mg, carmellosum natricum conexum corresp. natrium max. 1.08 mg, lactosum 142.5 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, pellicule: hydroxypropylcellulosum, hypromellosum, talcum, E 171, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), pro compresso obducto.

Articles (1)

Apremilast Leman 10 mg, 20 mg, 30 mg, comprimés pelliculés
Tabletten
4 + 4 + 19
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/08/2026
Professional SmPC
Français
18/08/2026
Professional SmPC
Italien
18/08/2026
Patient information leaflet
Allemand
23/07/2025
Patient information leaflet
Français
23/07/2025
Patient information leaflet
Italien
23/07/2025

Detailed composition

Substance Quantity Type Category
apremilastum
30.0 MG Substance Wirkstoff (Principe actif)
apremilastum
20.0 MG Substance Wirkstoff (Principe actif)
apremilastum
10.0 MG Substance Wirkstoff (Principe actif)
carmellosum natricum conexum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrium
- Substance HBESI
natrium
- Substance HBESI
natrium
- Substance HBESI
lactosum
95.0 MG Substance HBESI
lactosum
47.5 MG Substance HBESI
lactosum
142.5 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
talcum
- Substance HNIDK
talcum
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 172 (nigrum)
- Substance FTODK

Reimbursement information

Public price
CHF 141.10
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2025

Authorization holder

Leman SKL SA

1213 Lancy

Authorization information

Swissmedic authorization number
69514
Drug name
Apremilast Leman, comprimés pelliculés
Galenic form
FILM
ATC Code
L04AA32
Authorization status
Z
Dispensation category
B
First authorization
22/07/2025
Authorization expiration date
21/07/2030
IT number
07.15.0.
Domain
Human medicine

Packaging details

Description (FR)
APREMILAST Leman cpr pellic 10 mg 4+4+19 pce
Description (DE)
APREMILAST Leman Filmtabl 10 mg 4+4+19 Stk
Market launch
18/08/2025
Narcotic (BTM)
No

Original drug

Otezla, Filmtabletten
GTIN: 7680653460036
CHF 334.85
View original

Other packaging sizes

APREMILAST Leman cpr pellic 30 mg 56 pce
56 TABL
GTIN: 7680695140026
View
Buy us a coffee Explore the data